Skip to content

NC TREK NEO™ 1400250-25Recalls & reported problems

Abbott Vascular Inc. · NC TREK NEO™ Coronary Dilatation Catheter 2.50 X 25 mm / Rapid-Exchange · Class 2

All models of NC TREK NEO (45)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648232435), received between Mar 26, 2025 and Mar 12, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Rupture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Rupture2
  • Difficult to Advance1
  • Material Separation1
  • Off-Label Use1

Patient problems

  • Foreign Body In Patient1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 12, 2026Off-Label Use; Material Rupture; Material Separation; Difficult to Advance

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT DISTAL ANASTOMOSIS OF LEFT FEMORAL POPLITEAL BYPASS GRAFT WITH HEAVY CALCIFICATION. THE 2.5X25MM NC TREK NEO BALLOON DILATATION CATHETER (BDC) WAS ADVANCED WITH RESISTANCE DUE TO THE ANATOMY. THE BALLOON WAS INFLATED; HOWEVER, THE BALLOON RUPTURED DURING THE FIRST INFLATION. WHEN REMOVING THE BDC THE BALLOON SEPARATED AND REMAINS IN THE PATIENT. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Foreign Body In Patient

    MAUDE report 24584535 ↗
  • MalfunctionMar 26, 2025Material Rupture; Material Rupture

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN UNSPECIFIED CORONARY ARTERY. THE 2.5X25 MM NC TREK NEO BALLOON DILATATION CATHETER (BDC) WAS INFLATED AND IT WAS NOTED THAT THE BALLOON WAS PERFORATED [RUPTURED]. THERE WERE NO ADVERSE PATIENT EFFECTS AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21701971 ↗

Other Catheters, transluminal coronary angioplasty, percutaneous devices

All Catheters, transluminal coronary angioplasty, percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page